ES2123641T3 - Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9. - Google Patents

Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9.

Info

Publication number
ES2123641T3
ES2123641T3 ES93907050T ES93907050T ES2123641T3 ES 2123641 T3 ES2123641 T3 ES 2123641T3 ES 93907050 T ES93907050 T ES 93907050T ES 93907050 T ES93907050 T ES 93907050T ES 2123641 T3 ES2123641 T3 ES 2123641T3
Authority
ES
Spain
Prior art keywords
nucleic acid
acid sequences
sequences coding
complementary
interleukin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907050T
Other languages
English (en)
Inventor
Jean-Christophe Renauld
Catherine Druez
Snick Jacques Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Application granted granted Critical
Publication of ES2123641T3 publication Critical patent/ES2123641T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION DESCRIBE SECUENCIAS DE ACIDO NUCLEICO CODIFICADAS PARA LA MOLECULA DEL RECEPTOR (IL9 RLEUCINA 9. ESTAS SECUENCIAS SE PUEDEN EMPLEAR COMO MUESTRAS PARA IDENTIFICAR CELULAS QUE PRESENTAN LA MOLECULA, Y COMO AGENTES PARA TRANSFECTAR CELULAS RECEPTORAS.
ES93907050T 1992-03-09 1993-02-25 Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9. Expired - Lifetime ES2123641T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84734792A 1992-03-09 1992-03-09

Publications (1)

Publication Number Publication Date
ES2123641T3 true ES2123641T3 (es) 1999-01-16

Family

ID=25300394

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907050T Expired - Lifetime ES2123641T3 (es) 1992-03-09 1993-02-25 Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9.

Country Status (10)

Country Link
US (2) US5789237A (es)
EP (1) EP0643719B1 (es)
JP (1) JP3598386B2 (es)
AT (1) ATE172470T1 (es)
AU (1) AU669889B2 (es)
CA (1) CA2131719C (es)
DE (1) DE69321720T2 (es)
DK (1) DK0643719T3 (es)
ES (1) ES2123641T3 (es)
WO (1) WO1993018047A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690743B2 (en) * 1994-09-05 1998-04-30 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor
US6274708B1 (en) 1994-09-05 2001-08-14 Amrad Operations Pty Ltd. Mouse interleukin-11 receptor
US5965439A (en) * 1996-11-18 1999-10-12 The Regents Of The University Of California Host defense enhancement
CA2302936A1 (en) * 1997-09-19 1999-04-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
DE69943022D1 (de) * 1998-03-19 2011-01-20 Human Genome Sciences Rockville Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor
US6861227B2 (en) 1998-03-19 2005-03-01 Human Genome Sciences, Inc. Antibodies to cytokine receptor common gamma chain like
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
DE19947082B4 (de) * 1999-09-30 2005-02-10 Infineon Technologies Ag Integrierte Speicherzellenanordnung mit mindestens einem Kondensator und einem Transistor und Verfahren zur Herstellung einer integrierten Speicherzelle
AU2001272925A1 (en) 2000-05-26 2001-12-11 Immunex Corporation Use of interleukin-4 antagonists and compositions thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US4578335A (en) * 1984-05-21 1986-03-25 Immunex Corporation Interleukin 2 receptor
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
US4707443A (en) * 1985-04-19 1987-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
US4816565A (en) * 1985-08-13 1989-03-28 Tasuku Honjo Interleukin 2 receptor and a method for production thereof
US5030576A (en) * 1986-04-30 1991-07-09 Genentech, Inc. Receptors for efficient determination of ligands and their antagonists or agonists
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US5350683A (en) * 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5116951A (en) * 1990-09-19 1992-05-26 Ludwig Institute For Cancer Research Substantially pure interleukin-9 receptor and uses thereof
US5246701A (en) * 1990-10-05 1993-09-21 Ludwig Institute For Cancer Research Method for inhibiting production of IgE by using IL-9 inhibitors
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof

Also Published As

Publication number Publication date
EP0643719A4 (en) 1996-03-27
WO1993018047A1 (en) 1993-09-16
ATE172470T1 (de) 1998-11-15
US5789237A (en) 1998-08-04
JP3598386B2 (ja) 2004-12-08
CA2131719C (en) 2003-09-16
DK0643719T3 (da) 1999-06-28
EP0643719B1 (en) 1998-10-21
EP0643719A1 (en) 1995-03-22
DE69321720D1 (de) 1998-11-26
AU3779093A (en) 1993-10-05
AU669889B2 (en) 1996-06-27
CA2131719A1 (en) 1993-09-16
JPH07504816A (ja) 1995-06-01
US5962269A (en) 1999-10-05
DE69321720T2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
DE3578190D1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
DE69528061D1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
ATE466948T1 (de) Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
MX9203598A (es) Polipeptido novedoso y secuencias de adn que codifican para la sintesis de eritropoyetina.
ES2123641T3 (es) Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9.
DE3686969D1 (de) Haertbare zusammensetzung, verfahren zu ihrer herstellung und daraus gefertigte gegenstaende.
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
AR015687A2 (es) Gen aislado que codifica acil transferasa
FI961202A (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
ATE286123T1 (de) Klonierung von pheromon rezeptoren aus vertebraten und deren verwendungen
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK0714441T3 (da) Rekombinante Cladosporium herbarum allergener
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
PE20399A1 (es) Muteina ob
CO4230141A1 (es) Acc-sintasa de crucifera y sus usos
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
LV12722A (lv) Prv-1 gene and the use thereof
ATE53608T1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 643719

Country of ref document: ES